Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States

References

• Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350(1):48–58. doi:10.1056/NEJMra021678.
   PubMed Web of Science ®Google Scholar
• Kempen JH, O’Colmain BJ, Leske MC, et al. Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552–563. doi:10.1001/archopht.122.4.552.
   PubMed Web of Science ®Google Scholar
• Zhang X, Saaddine JB, Lee PP, et al. Eye care in the United States: do we deliver to high-risk people who can benefit most from it? Arch Ophthalmol. 2007;125(3):411–418. doi:10.1001/archopht.125.3.411.
   PubMedGoogle Scholar
• Schaneman J, Kagey A, Soltesz S, Stone J. The role of comprehensive eye exams in the early detection of diabetes and other chronic diseases in an employed population. Popul Health Manag. 2010;13(4):195–199. doi:10.1089/pop.2009.0050.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Executive summary: standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):S5–13. doi:10.2337/dc14-S014.
   PubMed Web of Science ®Google Scholar
• HEDIS 2009 Volume 2 Technical Update. October 1, 2008. National committee for quality accreditation. http://www.ncqa.org/portals/0/PolicyUpdates/HEDIS%20Technical%20Updates/09_CDC_Spec.pdf. Accessed February 23, 2015
   Google Scholar
• American Academy of Ophthalmology Preferred Practice Patterns Committee. Preferred Practice Pattern® Guidelines. Comprehensive Adult Medical Eye Evaluation. San Francisco, CA: American Academy of Ophthalmology; 2010. www.aao.org/ppp. Accessed February 23,2015.
   Google Scholar
• Handelsman Y, Mechanick JI, Blonde L, et al. AACE task force for developing diabetes comprehensive care plan. American association of clinical endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17(Suppl 2):1–53. doi:10.4158/EP.17.S2.1.
   PubMed Web of Science ®Google Scholar
• Brechner RJ, Cowie CC, Howie LJ, Herman WH, Will JC, Harris MI. Ophthalmic examination among adults with diagnosed diabetes mellitus. Jama. 1993;270:1714–1718. doi:10.1001/jama.1993.03510140074032.
   PubMed Web of Science ®Google Scholar
• Kuo S, Fleming BB, Gittings NS, et al. Trends in care practices and outcomes among Medicare beneficiaries with diabetes. Am J Prev Med. 2005;29:396–403. doi:10.1016/j.amepre.2005.08.010.
   PubMed Web of Science ®Google Scholar
• Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology. 2003;110(10):1952–1959. doi:10.1016/S0161-6420(03)00817-0.
   PubMed Web of Science ®Google Scholar
• Paksin-Hall A, Dent ML, Dong F, Ablah E. Factors contributing to diabetes patients not receiving annual dilated eye examinations. Ophthalmic Epidemiol. 2013;20(5):281–287. doi:10.3109/09286586.2013.789531.
   PubMed Web of Science ®Google Scholar
• Ryan DS, Coleman KJ, Lawrence JM, Harrison TN, Reynolds K. Optimal management of diabetes among overweight and obese adults. Am J Manag Care. 2014;20(1):e1–7.
   PubMed Web of Science ®Google Scholar
• Hatef E, Vanderver BG, Fagan P, Albert M, Alexander M. Annual diabetic eye examinations in a managed care medicaid population. Am J Manag Care. 2015;21(5):e297–302.
   PubMed Web of Science ®Google Scholar
• Sloan FA, Yashkin AP, Chen Y. Gaps in receipt of regular eye exams among medicare beneficiaries diagnosed with diabetes or chronic eye diseases. Ophthalmology. 2014;121(12):2452–2460. doi:10.1016/j.ophtha.2014.07.020.
   PubMed Web of Science ®Google Scholar
• Sloan FA, Brown DS, Carlisle ES, Picone GA, Lee PP. Monitoring visual status: why patients do or do not comply with practice guidelines. Health Serv Res. 2004;39(5):1429–1448. doi:10.1111/hesr.2004.39.issue-5.
   PubMed Web of Science ®Google Scholar
• Crosby MI, Shuman V. Physicians’ role in eye care of patients with diabetes mellitus–are we doing what we need to? J Am Osteopath Assoc. 2011;111(2):97–101.
   PubMedGoogle Scholar
• Hartnett ME, Key IJ, Loyacano NM, Horswell RL, Desalvo KB. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol. 2005;123(3):387–391. doi:10.1001/archopht.123.3.387.
   PubMedGoogle Scholar
• Kanter M, Martinez O, Lindsay G, Andrews K, Denver C. Proactive office encounter: a systematic approach to preventive and chronic care at every patient encounter. Perm J. 2010;14(3):38–43.
   PubMedGoogle Scholar
• Taylor-Phillips S, Mistry H, Leslie R, et al. Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. Br J Ophthalmol. 2016;100(1):105–114. doi:10.1136/bjophthalmol-2014-305938.
   PubMed Web of Science ®Google Scholar
• Maciejewski ML, Bryson CL, Perkins M, et al. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Am J Manag Care. 2010;16(1):e20–34.
   PubMed Web of Science ®Google Scholar
• Doshi JA, Zhu J, Lee BY, Kimmel SE, Volpp KG. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation. 2009;119(3):390–397. doi:10.1161/CIRCULATIONAHA.108.783944.
   PubMed Web of Science ®Google Scholar
• Patterson ME, Blalock SJ, Smith AJ, Murray MD. Associations between prescription copayment levels and β-blocker medication adherence in commercially insured heart failure patients 50 years and older. Clin Ther. 2011;33(5):608–616. doi:10.1016/j.clinthera.2011.04.022.
   PubMed Web of Science ®Google Scholar
• Campbell JD, Allen-Ramey F, Sajjan SG, Maiese EM, Sullivan S. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes. Am J Manag Care. 2011;17(10):703–710.
   PubMed Web of Science ®Google Scholar
• Clark B, DuChane J, Hou J, Rubinstein E, McMurray J, Duncan I. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications. J Manag Care Pharm. 2014;20(2):141–150.
   PubMed Web of Science ®Google Scholar
• Maciejewski ML, Farley JF, Parker J, Wansink D. Copayment reductions generate greater medication adherence in targeted patients. Health Aff (Millwood). 2010 November;29(11):2002–2008. doi:10.1377/hlthaff.2010.0571.
   PubMed Web of Science ®Google Scholar
• Zeng F, An JJ, Scully R, Barrington C, Patel BV, Nichol MB. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation. Value Health. 2010;13(6):846–852. doi:10.1111/j.1524-4733.2010.00730.x.
   PubMed Web of Science ®Google Scholar
• Judah G, Vlaev I, Gunn L, et al. Incentives in Diabetic Eye Assessment by Screening (IDEAS): study protocol of a three-arm randomized controlled trial using financial incentives to increase screening uptake in London. BMC Ophthalmol. 2016;16:28. doi:10.1186/s12886-016-0206-4.
   PubMed Web of Science ®Google Scholar
• Ellish NJ, Royak-Schaler R, Higginbotham EJ. Tailored and targeted interventions to encourage dilated fundus examinations in older African Americans. Arch Ophthalmol. 2011 December;129(12):1592–1598. doi:10.1001/archophthalmol.2011.190.
   PubMedGoogle Scholar
• Jones HL, Walker EA, Schechter CB, Blanco E. Vision is precious: a successful behavioral intervention to increase the rate of screening for diabetic retinopathy for inner-city adults. Diabetes Educ. 2010;36(1):118–126. doi:10.1177/0145721709356116.
   PubMed Web of Science ®Google Scholar
• Walker EA, Schechter CB, Caban A, Basch CE. Telephone intervention to promote diabetic retinopathy screening among the urban poor. Am J Prev Med. 2008;34(3):185–191. doi:10.1016/j.amepre.2007.11.020.
   PubMed Web of Science ®Google Scholar
• Zhang X, Norris SL, Saadine J, et al. Effectiveness of interventions to promote screening for diabetic retinopathy. Am J Prev Med. 2007;33(4):318–335. doi:10.1016/j.amepre.2007.05.002.
   PubMed Web of Science ®Google Scholar
• Storey PP, Murchison AP, Pizzi LT, et al. Impact of Physician Communication on Diabetic Eye Examination Adherence: results From a Retrospective Cohort Analysis. Retina. 2016;36(1):20–27. doi:10.1097/IAE.0000000000000652.
   PubMed Web of Science ®Google Scholar